Related Experiment Video
Updated: May 17, 2026

Determining the Functional Status of the Corticospinal Tract Within One Week of Stroke
Published on: February 22, 2020
Prediction of Motor Outcome in Patients With Severe Upper Limb Impairment After Stroke Using Motor Evoked Potentials
Rikke Møller Feldbæk1, Iris Charlotte Brunner1,2, Camilla Biering Lundquist1
1Hammel Neurorehabilitation Center and University Research Clinic, Denmark.
Abstract:
IntroductionIdentifying the individuals who may achieve a favorable upper limb function after severe stroke-related upper limb impairment remains challenging. Incorporating a biomarker, motor-evoked potential (MEP), may improve prediction accuracy.ObjectivesTo evaluate the prediction accuracy of baseline MEP status for upper limb motor outcome at 3 months post-stroke and to determine the predictive association between MEP status and upper limb motor outcome.MethodsThis prospective longitudinal cohort study included patients ≥18 years of age with severe upper limb impairment within 4 weeks post-stroke. MEP status was examined with transcranial magnetic stimulation at baseline. The primary outcome was the Fugl-Meyer Assessment upper extremity score (FMA) at follow-up 3 months post-stroke. The accuracy was determined by comparing MEP status (MEP present or absent) with 2 FMA outcome categories (FMA ≤ or >17) including calculation of sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). The predictive association between MEP status and 3 FMA outcome categories (FMA: 0-4; 5-17; and 18-66) was examined using ordinal logistic regression.ResultsOf 80 included patients, 74 completed follow-up. Overall accuracy was 75.7% (95% confidence interval [CI]: 64.3%-84.9%). Specificity was 80.3% (95% CI: 68.2%-89.4%), sensitivity 53.8% (95% CI: 25.1%-80.8%), PPV 36.8% (95% CI: 16.3%-61.6%), and NPV 89.1% (CI 95% 77.8%-95.9%). MEP presence was strongly associated with a higher motor outcome category at follow-up (odds ratio: 6.6; 95% CI: 2.1-21.9; P = .001).ConclusionsAssessing MEP status is a clinically relevant approach for predicting upper limb motor outcomes in patients with severe upper limb impairment after stroke.Trial Registry NameiTMS-Implementing Transcranial Magnetic Stimulation to Assess Cortico-spinal Tract Integrity. https://clinicaltrials.gov/study/NCT06153017. Registration number: NCT06153017.
